STOCK TITAN
  1. Home
  2. BZYR

BURZYNSKI RESH INSTITUTE (BZYR) Stock Price, News & Analysis

BZYR OTC
Published by Stock Titan Data refreshed

What Changed

Price Move History

Daily moves over 5%
74 93 sessions, September 12, 2025 to September 14, 2026
Largest daily move
+96.9% close of January 22, 2026
1-year change
-95.7% closing prices, September 12, 2025 to September 14, 2026

Company Description

BURZYNSKI RESH INSTITUTE (OTC: BZYR) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $256.3K.

BZYR has declined 95.7% over the past year. The last closing price was $0.0020.

For FY2025, BURZYNSKI RESH INSTITUTE reported revenue of $0 and diluted earnings per share of -$0.01.

This page collects what Stock Titan holds for BZYR, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart
$—
-
-
Last updated:
-95.7%
Performance 1 year
$256.3K
Market Cap
131.4M
Shares outstanding

BURZYNSKI RESH INSTITUTE (BZYR) closed at $0.0020 on September 14, 2026. Over the past 12 months, the price has lost 95.7%.

See what a $1,000 investment in BZYR would be worth today

BZYR Metrics & Rankings

Market Cap
$256.3K
View ranking
Revenue
$0.0
#3,534
Month to date
-55.6%
View ranking
YTD
-89.5%
View ranking

Price returns through September 14, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.

Latest News

View All

No recent news available for BZYR.

SEC Filings

View All

[8-K] Funding shortfall puts Burzynski (BZYR) SEC reporting and trading at risk

[8-K] BURZYNSKI RESEARCH INSTITUTE INC Reports Material Event

[10-Q] BURZYNSKI RESEARCH INSTITUTE INC Quarterly Earnings Report

[10-Q] BZYR Q2 2025: Minimal Cash, Ongoing Clinical Hold, Equity Deficit

[8-K/A] Burzynski Research (BZYR) replaces PKF with M&K CPA’s as independent auditor

BURZYNSKI RESH INSTITUTE has filed 5 recent SEC filings, including 2 Form 8-K, 2 Form 10-Q, 1 Form 8-K/A. The most recent filing was submitted on May 12, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all BZYR SEC filings →

Financial Highlights

View Full Financials

Diluted earnings per share stood at -$0.01.

$0
Revenue (FY2025)
-$0.01
Diluted EPS (FY2025)
—
Net Income (FY2025)
—
Operating Cash Flow
—
Net Profit Margin
—
Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Short interest in BURZYNSKI RESH INSTITUTE (BZYR) currently stands at 285 shares, representing 0.0% of the float. Since October 2025, short interest has decreased by 83.8%. This relatively low short interest suggests limited bearish sentiment.

Days to Cover History

Last 12 Months

Days to cover for BURZYNSKI RESH INSTITUTE (BZYR) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed.

BZYR Company Profile & Sector Positioning

BURZYNSKI RESH INSTITUTE (BZYR) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC.

Frequently Asked Questions

What is the current stock price of BURZYNSKI RESH INSTITUTE (BZYR)?

The current stock price of BURZYNSKI RESH INSTITUTE (BZYR) is $0.002 as of September 14, 2026.

What is the market cap of BURZYNSKI RESH INSTITUTE (BZYR)?

The market cap of BURZYNSKI RESH INSTITUTE (BZYR) is approximately $256.3K. Learn more about what market capitalization means .

What is the revenue of BURZYNSKI RESH INSTITUTE (BZYR) stock?

The FY2025 revenue of BURZYNSKI RESH INSTITUTE (BZYR) is $0, from its most recent completed fiscal year.

What is the earnings per share (EPS) of BURZYNSKI RESH INSTITUTE (BZYR)?

The diluted earnings per share (EPS) of BURZYNSKI RESH INSTITUTE (BZYR) is -$0.01 for FY2025, its most recent completed fiscal year. Learn more about EPS .